In their guest commentary, Evan Behrle, Dr. Shelly Choo and Dr. Leana Wen discuss the Health Department's Levels of Care initiative. 

In many doctor's offices and hospitals across the country, the response to someone seeking addiction treatment is simple: "We don't do that here."We are living through the deadliest drug epidemic in American history. Overdose is now the leading cause of death for Americans under age 50. "We don't do that here"

Read the entire story here.

Baltimore health officials are urging the Trump administration to use a law, which was last considered by the Bush administration during the 2001 anthrax scare , to cut the price of the opioid-over

Renowned New York Times journalist Nicholas Kristof will speak on May 3 at the Peabody Library in Baltimore on the need to build a fairer society. Among those attending will be Baltimore Commissioner of Health Dr. Leana Wen, former Maryland Sen. Barbara Mikulski and Robert L. Caret, chancellor of the University System of Maryland. The program will also feature Dr. Wen, who will speak about public health in Baltimore.

Read the entire story.

Baltimore hospitals will have new incentives for better addressing the opioid crisis—and sharing best practices with their counterparts across the city—under a new initiative announced by the city's top officials Monday.

Read the entire story.

The Baltimore City Health Department is looking to the Trump administration to expand access to the overdose reversal drug naloxone. It’s not the supply but the cost of the drug that jurisdictions like Baltimore are struggling with.

Watch the full video here.

The Trump administration should invoke government authority to slash prices of a life-saving overdose drug or provide funding to expand access amid the coast-to-coast opioid epidemic, Baltimore’s health department and a national advocacy group said Thursday.

Read the entire story.

Baltimore is making a first-of-its-kind request that the Trump administration use its existing authority to lower the cost of opioid overdose reversal drug naloxone in order to provide it to health care workers and law enforcement.

Read the entire story.

The Baltimore health department and a consumer advocacy group are urging the Trump administration to sidestep patents on a pair of opioid overdose antidotes in order to combat the opioid crisis.

Read the entire story.

The Trump administration should fight the opioid epidemic with a novel weapon, say the city of Baltimore and a consumer advocacy group: overriding patents on the widely-used overdose antidote naloxone.

Read the entire story.

Putting drug prices front and center at the Food and Drug Law Institute's (FDLI) annual conference Thursday, FDA Commissioner Scott Gottlieb took on some of the current rules and restrictions that prevent true market-based pricing and competition.

As Gottlieb was speaking at FDLI, the government watchdog group Public Citizen and the Baltimore City Health Department were calling on the Trump administration to address the high price of specific drugs used to reverse life-threatening opioid overdoses. The groups urged the government to use its march-in rights to enable generic competition for Kaleo Inc.'s naloxone auto-injector Evzio and Adapt Pharma Ltd.'s naloxone nasal spray Narcan.

Read the entire story.